Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 6/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / -||UN / IM|
Administered by: Other Purchased by: Unknown
Symptoms: Adverse event
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Diagnostic Lab Data:
CDC 'Split Type': US0095075131706USA000362
Write-up:This spontaneous report was received from a physician via a company representative concerning an unspecified patient of an unknown age and gender. The patient''s concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with GARDASIL intramuscularly (dose, frequency, lot number and expiration date were not reported) for prevention of human papillomavirus (prophylaxis). The physician reported that he was hearing that somebody in a town close, on an unknown date, experienced an unspecified disabling effect (adverse event). At the time of reporting, the outcome of the event was not reported. The causal relationship between the event and GARDASIL was not reported. The reporter considered the adverse event as a disabling event. Additional information is not expected as there are no contact details available.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166